16D0 Tuluc, Madalina - Thomas Jefferson University - Thomas Jefferson University

Madalina Tuluc, MD, PhD

Contact Dr. Tuluc

132 South 10th Street
285R Main
Philadelphia, PA 19107

(215) 955-7524
(215) 923-1969 fax

Most Recent Peer-reviewed Publications

  1. Malignant Sarcomatous Transformation of Fibrous Dysplasia
  2. Salivary duct carcinoma: The predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression
  3. Malignant Sarcomatous Transformation of Fibrous Dysplasia
  4. Orbital involvement by nut midline carcinoma
  5. Tumor microenvironment in head and neck squamous cell carcinoma
  6. Thyroid Cytology
  7. Recurrent epistaxis and nasal congestion
  8. Current management of locally advanced head and neck cancer: The combination of chemotherapy with locoregional treatments
  9. False-positive fna due to highly sensitive braf assay
  10. Chondrosarcoma of the hyoid bone: Case report and review of current management options
  11. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma
  12. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients
  13. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment RAS and NFκB target stromal MCT4
  14. Cancer metabolism, stemness and tumor recurrence : MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
  15. Clinical experience transitioning from IMRT to VMAT for head and neck cancer
  16. Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis
  17. Uncommon Tumors of the Oral Cavity and Adjacent Structures
  18. The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma
  19. A Radiolucent Lesion in the Posterior Mandible
  20. Ulcerative gastritis secondary to Epstein-Barr viral infection